Non-Inferiority Trials, Please, US FDA Implores Rheumatoid Arthritis Sponsors

 
• By Bridget Silverman
  
Arthritic hands
The US FDA would like to see non-inferiority trial designs in rheumatoid arthritis drug development. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D